10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Brinzolamide Ophthalmic Suspension 1.0% vials in dosage form, from India
Issued April 21, 2017 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN2 N285019 (April 21, 2017)
Tariff classification
HTS codes: 3004.90.9285
Headings: 3004
Product description
Brinzolamide Ophthalmic Suspension 1.0% in 10 ml vials is a medicinal preparation containing Brinzolamide, a carbonic anhydrase inhibitor, as the active ingredient. It decreases the pressure in the eye and is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. In your letter, you indicated that you will be importing 600 vials for in vivo testing.
CBP rationale
The applicable subheading for the Brinzolamide Ophthalmic Suspension 1.0% in 10 ml vials in dosage form will be 3004.90.9285, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments (…) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (…) Other: Other: Other: Medicaments primarily affecting the eyes, ears or respiratory system: Other: Other.
Full text
N285019 April 21, 2017 CLA-2-30:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9285 Mr. Thomas M. Speace Sentiss Pharmaceuticals LLC 107 Avenida de la Estrella, Suite 102 San Clemente, CA 92672 RE: The tariff classification of Brinzolamide Ophthalmic Suspension 1.0% vials in dosage form, from India Dear Mr. Speace: In your letter dated April 3, 2017, you requested a tariff classification ruling. Brinzolamide Ophthalmic Suspension 1.0% in 10 ml vials is a medicinal preparation containing Brinzolamide, a carbonic anhydrase inhibitor, as the active ingredient. It decreases the pressure in the eye and is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. In your letter, you indicated that you will be importing 600 vials for in vivo testing. The applicable subheading for the Brinzolamide Ophthalmic Suspension 1.0% in 10 ml vials in dosage form will be 3004.90.9285, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments (…) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (…) Other: Other: Other: Medicaments primarily affecting the eyes, ears or respiratory system: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division -
More rulings on the same tariff codes
The tariff classification of Timolol Maleate Ophthalmic Gel Forming Solution (Eye Drops) 0.25% and 0.5% in dosage form, from India
The tariff classification of Ambroxol Hydrochloride Tablets in dosage form, from Turkey
The tariff classification of Arformoterol Tartrate Inhalation Solution in dosage form, from Germany
The tariff classification of Formoterol Fumarate Inhalation Solution in dosage form, from Germany
The tariff classification of Ketorolac Tromethamine Tablets, Levothyroxine Sodium Tablets, and Roflumilast Tablets in dosage form, from India
The tariff classification of Levalbuterol Hydrochloride vials in dosage form, from India
The tariff classification of Albuterol Tablets and Azelastine Hydrochloride Nasal Spray in dosage form, from India
The tariff classification of Cyclosporine Ophthalmic Emulsion 0.05% in dosage form, from Turkey
The tariff classification of Acyclovir Sodium Injection and Acetazolamide Tablets in dosage form, from India
The tariff classification of Doxepin Hydrochloride Capsules and Acetazolamide Extended-Release Capsules in dosage form, from India
Follow N285019
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.